Clofibric Acid
"Clofibric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
| Descriptor ID |
D002995
|
| MeSH Number(s) |
D02.241.081.114.968.500.500 D02.355.726.305.500 D02.455.426.559.389.657.654.305.500
|
| Concept/Terms |
Clofibric Acid- Clofibric Acid
- Clofibrinic Acid
- p-Chlorophenoxyisobutyric Acid
- 2-(4-Chlorophenoxy)-2-methylpropionic Acid
|
Below are MeSH descriptors whose meaning is more general than "Clofibric Acid".
Below are MeSH descriptors whose meaning is more specific than "Clofibric Acid".
This graph shows the total number of publications written about "Clofibric Acid" by people in this website by year, and whether "Clofibric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clofibric Acid" by people in Profiles.
-
Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol. 2008 Apr; 51(4):331-51.
-
McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol. 2007 Aug; 60(8):812-8.
-
Dellavalle RP, Drake A, Graber M, Heilig LF, Hester EJ, Johnson KR, McNealy K, Schilling L. Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD003697.